Brokerages predict that Varex Imaging Corp (NASDAQ:VREX) will post sales of $193.61 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Varex Imaging’s earnings. The highest sales estimate is $194.02 million and the lowest is $193.20 million. The business is expected to report its next quarterly earnings report on Monday, January 1st.
On average, analysts expect that Varex Imaging will report full year sales of $193.61 million for the current year, with estimates ranging from $792.22 million to $792.30 million. For the next fiscal year, analysts anticipate that the business will report sales of $814.96 million per share, with estimates ranging from $814.70 million to $815.22 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that cover Varex Imaging.
Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Thursday, November 9th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.07. The firm had revenue of $216.00 million for the quarter, compared to analyst estimates of $213.73 million. The firm’s quarterly revenue was up 25.5% compared to the same quarter last year.
Varex Imaging (NASDAQ:VREX) opened at $40.72 on Friday. The company has a current ratio of 3.26, a quick ratio of 1.72 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $1,540.00 and a PE ratio of 29.94. Varex Imaging has a 52-week low of $25.00 and a 52-week high of $41.99.
In related news, insider Sunny Sanyal sold 50,000 shares of the stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $36.50, for a total transaction of $1,825,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Large investors have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. bought a new stake in Varex Imaging in the second quarter valued at approximately $112,000. Howard Hughes Medical Institute bought a new stake in Varex Imaging in the second quarter valued at approximately $134,000. Oppenheimer Asset Management Inc. bought a new stake in Varex Imaging in the second quarter valued at approximately $136,000. Pinebridge Investments L.P. bought a new stake in Varex Imaging in the second quarter valued at approximately $167,000. Finally, Tufton Capital Management bought a new stake in Varex Imaging in the third quarter valued at approximately $201,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.com-unik.info/2018/01/06/varex-imaging-corp-vrex-expected-to-announce-quarterly-sales-of-193-61-million.html.
About Varex Imaging
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Varex Imaging? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Varex Imaging and related companies.